1. Van Tulder MW, Touray T, Furlan AD et al. Cochrane Back Review Group. Muscle relaxants for nonspecific low back pain: a systematic review within the framework of the cochrane collaboration. Spine 2003; 28 (17): 1978–92.
2. Rives PA, Douglass AB. Evaluation and treatment of low back pain in family practice. J Am Board Fam Pract 2004; 17: S23–31.
3. Leiphart JW, Dills CV, Levy RM. Alpha2-adrenergic receptor subtype specificity of intrathecally administered tizanidine used for analgesia for neuropathic pain. J Neurosurg 2004; 101 (24): 641–7.
4. Moon DE, Lee DH, Han HC et al. Adrenergic sensitivity of the sensory receptors modulating mechanical allodynia in a rat neuropathic pain model. Pain 1999; 80: 589–95.
5. Hutchinson DR, Daniels F. A multinational study in general practice to evaluate the effectiveness and tolerability of tizanidine in the treatment of painful muscle spasms. Br J Clin Res 1990; 1: 39–48.
6. Jain NK, Kulkarni SK, Singh A. Modulation of NSAID-induced antinociceptive and anti-inflammatory effects by alpha2-adrenoceptor agonists with gastroprotective effects. Life Sci 2002; 70 (24): 2857–69.
7. Berry H, Hutchinson DR. Tizanidine and ibuprofen in acute low-back pain: Results of a double-blind multicentre study in general practice. J Intern Med Res 1988; 16: 83–91.
8. Sirdalud ternilin Asia-Pacific study group. Efficacy and gastroprotective effects of tizanidine plus diclofenac versus placebo plus diclofenac in patients with painful muscle spasm. Curr Ther Res 1998; 59: 13–22.
Авторы
О.В.Воробьева
Кафедра нервных болезней ФППОВ ГБОУ ВПО Первый МГМУ им. И.М.Сеченова Минздрава России